Paul Adepoju
Paul Adepoju
The Lancet Hiv
The Lancet Hiv
Paul Adepoju
Paul Adepoju
Reducing HIV incidence and mortality: two sides of the same coin in the approach to ending AIDS [0.03%]
减少HIV新发感染和死亡：从终结艾滋病的角度实现正反面共赢的方法
Joseph N Jarvis,Peter Ehrenkranz,David S Lawrence et al.
Joseph N Jarvis et al.
HIV programmes globally continue to face two persistent challenges: advanced HIV disease and high HIV incidence. These issues are often viewed separately, with advanced HIV disease viewed as a late-stage clinical failure and high HIV incide...
Safety and pharmacokinetics of dolutegravir dispersible tablets and oral films in term neonates exposed to HIV in South Africa (PETITE-DTG study): an open-label, randomised, phase 1/2 trial [0.03%]
南非新生儿中暴露于人体免疫缺陷病毒的分散片和口服薄膜剂多替拉韦的安全性和药代动力学（PETITE-DTG研究）：一项开放性、随机、一期/二期临床试验
Adrie Bekker,Nicolas Salvadori,Helena Rabie et al.
Adrie Bekker et al.
Background: Dolutegravir is not recommended for neonates (age 28 days or younger) due to the absence of dosing guidelines and safety information. We evaluated the multidose pharmacokinetics and safety of two paediatric do...
Kimesh Loganathan Naidoo,Moherndran Archary
Kimesh Loganathan Naidoo
Retraction and republication-HIV-related outcomes among migrants living in Europe compared with the general population: a systematic review and meta-analysis [0.03%]
撤稿和重发-与欧洲一般人群相比生活在欧洲的移民的艾滋病相关结果：系统评价和meta分析
The Lancet Hiv Editors
The Lancet Hiv Editors
HIV-related outcomes among migrants living in Europe compared with the general population: a systematic review and meta-analysis [0.03%]
与普通人群相比欧洲移民的艾滋病结果：系统评价和.meta.分析
Francesco Vladimiro Segala,Francesco Di Gennaro,Luisa Frallonardo et al.
Francesco Vladimiro Segala et al.
Background: Compared with the general population, international migrants arriving in Europe face severe socioeconomic challenges that result in higher HIV prevalence and limited access to health care, potentially leading ...